Tomi Häkkinen

No ORCID on file · 1 paper in corpus
2021
·doi:10.21203/rs.3.rs-384422/v1

Abstract Prostate cancer is heterogeneous and patients would benefit from methods that stratify those who are likely to respond to systemic therapy. We employed single-cell assays for transposase-accessible chromatin (ATAC) and RNA sequenc…